Bringing the fundamentals into focus…
Back to Neurocrine Biosciences, Inc.
How Neurocrine Biosciences, Inc. stacks up
NBIX · against 1,216 other Healthcare companies
Growth
87/ 100
Near the top of its peers.
Ranked #154 of 1,217 · scores higher than 87% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including NBIX · Click a bar to see the companies
Why growth scores 87?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 86% of peers. Earnings per share growth: 97.6% vs peer median 9.8%
- faster revenue growth over three years: stronger than 86% of peers. 3-year revenue growth: 26.3% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 87% of peers. Revenue growth: 34.4% vs peer median 6.1%
Metric by metric
Position: dot = NBIX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NBIX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 34.4% | 6.1% | 87% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 97.6% | 9.7% | 86% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 26.3% | 5.8% | 86% | 33% |
Ranking by growth score
Top 5 and the companies ranked around NBIX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 154 | 188M CHF (≈$216M) | 87 | 74 | |
| 154 | 1.9B USD | 87 | 68 | |
| 154 | 27.5B NZD (≈$16.5B) | 87 | 69 | |
| 154 | 1.8B USD | 87 | 80 | |
| 154 | 16.8B USD | 87 | 75 | |
| 154 | 915M USD | 87 | 57 | |
| 154 | 20.0B AUD (≈$13.2B) | 87 | 77 | |
| 154 | 10.4B USD | 87 | 70 | |
| 154 | 182.3B INR (≈$2.2B) | 87 | 66 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score